Article Information
History
- October 17, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Amrita K Cheema1,2,
- Yaoxiang Li1,
- Joanna Moulton1,
- Michael Girgis1,
- Stephen Y. Wise3,4,
- Alana Carpenter3,4,
- Oluseyi O. Fatanmi3,4 and
- Vijay K. Singh3,4,*
- 1Department of Oncology, Lombardi Comprehensive Cancer Center, Department of Biochemistry
- 2Molecular and Cellular Biology, Georgetown University Medical Center, Washington, DC, USA
- 3Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
- 4Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
- ↵*Corresponding author:
Vijay K. Singh, Ph.D., Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA, Phone: 301-295-2347, e-mail: vijay.singh{at}usuhs.edu